Mattel Inc vs Revvity Inc — how do they compare? Mattel Inc trades at $14.68 (market cap $4.30B), while Revvity Inc trades at $114.91 (market cap $12.91B). The key difference: Revvity Inc is far larger — about 3× Mattel Inc's market cap, and Revvity Inc pays a 0.24% dividend while Mattel Inc pays none. Which is the better fit depends on your goals.
| MAT | RVTY | |
|---|---|---|
Market Cap | $4.30B | $12.91B |
Sector | Consumer Cyclical | Technology |
52-Week High | $22.16 | $117.75 |
52-Week Low | $13.05 | $82.26 |
Enterprise Value | $6.52B | $15.23B |
Dividend Yield | — | 0.24% |
Signals from Pluang's Aura AI — not financial advice
Mattel (MAT) trades at $14.74, down 0.34% today, with a bullish technical signal from moving averages and oversold RSI levels. Recent Q2 2026 earnings missed estimates despite 10% revenue growth, reflecting margin pressure from higher costs. The company maintains solid profitability with a 7.78% net margin and attractive valuation at a P/E of 11.22. Cash flow turned negative in 2025 due to increased financing outflows, though operations remain cash-generative.
Outlook is mixed: analyst consensus leans buy (53%) with a $14 price target, but rising expenses and toy market volatility pose risks. The stock's appeal hinges on execution of its entertainment-driven growth strategy and cost management amid economic headwinds.
No Aura AI signal available yet.
Trailing returns across standard periods
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →